Mednet Logo
HomePediatric Hematology/OncologyQuestion

How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?

1 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · FibroFighters Foundation

Hello,

Indirect bilirubin is from hemolysis, not cholestasis (a few exceptions from rare syndromes), so not associated with stones, and would not expect ursodiol to help. It's a marker of how bad the sickling is - along with LDH, reticulocyte count, and MCHC (which measures cell density, i.e., irrev...

Register or Sign In to see full answer

How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)? | Mednet